Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): A randomised, multicentre, placebo-controlled trial

The Lancet

Volumn 386, Issue 10004, 2015, Pages 1649-1658

  Grainger, John D ^a,q   Locatelli, Franco ^b   Chotsampancharoen, Thirachit ^c   Donyush, Elena ^d   Pongtanakul, Bunchoo ^e   Komvilaisak, Patcharee ^f   Sosothikul, Darintr ^g   Drelichman, Guillermo ^h   Sirachainan, Nongnuch ⁱ   Holzhauer, Susanne ^j   Lebedev, Vladimir ^k   Lemons, Richard ^l   Pospisilova, Dagmar ^m   Ramenghi, Ugo ⁿ   Bussel, James B ^o   Bakshi, Kalpana K ^p   Iyengar, Malini ^p   Chan, Geoffrey W ^p   Chagin, Karen D ^p   Theodore, Dickens ^p   Marcello, Lisa M ^p   Bailey, Christine K ^p   more..

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF PAVIA   (Italy)

^c PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^d Izmaylovskaya Children's City Clinical Hospital   (Russian Federation)

^e MAHIDOL UNIVERSITY   (Thailand)

^f KHON KAEN UNIVERSITY   (Thailand)

^g CHULALONGKORN UNIVERSITY   (Thailand)

^h HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

ⁱ MAHIDOL UNIVERSITY   (Thailand)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k GUZ Regional Children's Clinical Hospital   (Russian Federation)

^l PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^m UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

ⁿ REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^o WEILL CORNELL MEDICAL COLLEGE   (United States)

^p GLAXOSMITHKLINE   (United States)

^q ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ELTROMBOPAG; PLACEBO; BENZOIC ACID DERIVATIVE; HYDRAZINE DERIVATIVE; PYRAZOLE DERIVATIVE; THROMBOPOIETIN RECEPTOR;

ABDOMINAL PAIN; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARGENTINA; ARTICLE; ASEPTIC MENINGITIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; CHILD; CHRONIC IMMUNE THROMBOCYTOPENIA; CONTROLLED STUDY; COUGHING; CZECH REPUBLIC; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; DRUG SAFETY; EPISTAXIS; FEMALE; FEVER; GERMANY; GINGIVITIS; HONG KONG; HUMAN; HYPERTENSIVE CRISIS; INFLUENZA; ISRAEL; ITALY; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PETECHIA; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINOPHARYNGITIS; RUSSIAN FEDERATION; SPAIN; TAIWAN; THAILAND; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES; UPPER ABDOMINAL PAIN; UPPER RESPIRATORY TRACT INFECTION; VOMITING; AGONISTS; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; INFANT; PRESCHOOL CHILD; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

ADOLESCENT; BENZOATES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDRAZINES; INFANT; MALE; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; PYRAZOLES; RECEPTORS, THROMBOPOIETIN; TREATMENT OUTCOME;

EID: 84945472937     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)61107-2     Document Type: Article

References (32)

1. PJ Ballem, GM Segal, JR Stratton, T Gernsheimer, JW Adamson, SJ Slichter Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance J Clin Invest 80 1987 33 40
2. R McMillan, L Wang, A Tomer, J Nichol, J Pistillo Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP Blood 103 2004 1364 1369
3. MM Reid Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome Arch Dis Child 72 1995 125 128
4. A Hedman, JI Henter, I Hedlund, G Elinder Prevalence and treatment of chronic idiopathic thrombocytopenic purpura of childhood in Sweden Acta Paediatr 86 1997 226 227
5. B Zeller, J Helgestad, M Hellebostad et al. Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration Pediatr Hematol Oncol 17 2000 551 558
6. F Rodeghiero, R Stasi, T Gernsheimer et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group Blood 113 2009 2386 2393
7. JN George, SH Woolf, GE Raskob et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology Blood 88 1996 3 40
8. CE Neunert, GR Buchanan, P Imbach et al. Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS) Blood 121 2013 4457 4462
9. C Neunert, W Lim, M Crowther et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia Blood 117 2011 4190 4207
10. D Provan, R Stasi, AC Newland et al. International consensus report on the investigation and management of primary immune thrombocytopenia Blood 115 2010 168 186
11. V Blanchette, P Imbach, M Andrew et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura Lancet 344 1994 703 707
12. CM Bennett, ZR Rogers, DD Kinnamon et al. Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura Blood 107 2006 2639 2642
13. N Cooper, JB Bussel The long-term impact of rituximab for childhood immune thrombocytopenia Curr Rheumatol Rep 12 2010 94 100
14. VL Patel, M Mahevas, SY Lee et al. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia Blood 119 2012 5989 5995
15. CE Neunert, BC Bright, GR Buchanan Severe chronic refractory immune thrombocytopenic purpura during childhood: a survey of physician management Pediatr Blood Cancer 51 2008 513 516
16. N Vianelli, F Palandri, N Polverelli et al. Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years Haematologica 98 2013 875 880
17. KKW Wang, C Charles, NM Heddle et al. Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy Health Expect 17 2014 809 817
18. CL Erickson-Miller, E Delorme, SS Tian et al. Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist Stem Cells 27 2009 424 430
19. J Bussel, P Garcia de Miguel, J Despotovic et al. Eltrombopag treatment of childhood persistent and chronic immune thrombocytopenia: final results of the PETIT study (TRA108062): a phase 2, placebo-controlled clinical trial Haematologica 99 2014 S733 (abstr).
20. G Cheng, MN Saleh, C Marcher et al. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study Lancet 377 2011 393 402
21. M Strullu, J Rakotonjanahary, E Tarral et al. Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQL 4.0 Generic Core Scales: a study on behalf of the pays de Loire pediatric hematology network Health Qual Life Outcomes 11 2013 193
22. JD Grainger, NL Young, VS Blanchette, RJ Klaassen Quality of life in immune thrombocytopenia following treatment Arch Dis Child 98 2013 895 897
23. N Bisharat, H Omari, I Lavi, R Raz Risk of infection and death among post-splenectomy patients J Infect 43 2001 182 186
24. S Boyle, RH White, A Brunson, T Wun Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia Blood 121 2013 4782 4790
25. SY Kristinsson, G Gridley, RN Hoover, D Check, O Landgren Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up Haematologica 99 2014 392 398
26. DM Arnold, NM Heddle, J Carruthers et al. A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia Blood 119 2012 1356 1362
27. Y Liang, L Zhang, J Gao, D Hu, Y Ai Rituximab for children with immune thrombocytopenia: a systematic review PLoS One 7 2012 e36698
28. JB Bussel, G Cheng, MN Saleh et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura N Engl J Med 357 2007 2237 2247
29. MN Saleh, JB Bussel, G Cheng et al. Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study Blood 121 2013 537 545
30. JB Bussel, MN Saleh, RSM Wong et al. Update on the safety and efficacy of EXTENDed treatment with eltrombopag (EPAG) in adults with chronic immune thrombocytopenia (ITP) Blood 122 2013 2315 (abstr).
31. JB Bussel, GR Buchanan, DJ Nugent et al. A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia Blood 118 2011 28 36
32. JB Bussel, L Hsieh, GR Buchanan et al. Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP) Pediatr Blood Cancer 62 2015 208 213